UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	Evaluation of the effect of magnesium oxide on the pharmacokinetics of levodopa/carbidopa
Title of the study (Brief title)	pharmacokinetic interaction between levodopa/carbidopa and magnesium oxide
Region	Japan

Condition
Condition	healthy male and female
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	to evaluate the effect of magnesium oxide on the pharmacokinetics of levodopa/carbidopa
Basic objectives2	Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	pharmacokinetics of levodopa and carbidopa
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Single arm
Randomization	Non-randomized
Randomization unit
Blinding	Open -no one is blinded
Control	Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	1
Purpose of intervention	Treatment
Type of intervention	Medicine
Interventions/Control_1	levodopa/carbidopa, wash out, with magnesium oxide
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	45 years-old >=
Gender	Male and Female
Key inclusion criteria	The investigators must ensure that all subjects being considered meet the following inclusion criteria: 1) Japanese healthy male or female who is capable to understand and sign the informed consent 2) 20-45 years of age 3) BMI 17.6-26.4 4) good health as determined by physical examination, vital signs and laboratory tests.
Key exclusion criteria	The investigators must ensure that all subjects being considered meet the following exclusion criteria or conditions: 1) history of allergy to any drugs 2) medical attention within 2 months prior to participation 3) donation of 200 mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4) donation of 400 mL or more of blood within 12 weeks prior to participation 5) recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6) history of drug abuse 7) alcohol abuse. 8) taking drugs or healthy foods which may affect drug metabolism
Target sample size	10

Research contact person
Name of lead principal investigator	Shunji Matsuki
Organization	LTA
Division name	Fukuoka Mirai Hospital
Address	3-5-1, Kashiiteruha, Higashi-ku, Fukuoka
TEL	092-662-3608
Email	shunji-matsuki@lta-med.com

Public contact
Name of contact person	Miyuki Kimura
Organization	LTA
Division name	Fukuoka Mirai Hospital
Address	3-5-1, Kashiiteruha, Higashi-ku, Fukuoka
TEL	092-662-3608
Homepage URL
Email	miyuki-kimura@lta-med.com

Sponsor
Institute	Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University
Institute
Department

Funding Source
Organization	Japan Research Foundation for Clinical Pharmacology
Organization
Division
Category of Funding Organization	Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2016 Year 12 Month 13 Day

Progress
Recruitment status	Completed
Date of protocol fixation	2016 Year 11 Month 14 Day
Anticipated trial start date	2016 Year 12 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information

Management information
Registered date	2016 Year 12 Month 12 Day
Last modified on	2017 Year 06 Month 13 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029019